Gut microbiota and non-alcoholic fatty liver disease-Reference-Cited by-同舟云学术

Gut microbiota and non-alcoholic fatty liver disease

Published:2015-12 Issue:6 Volume:14 Page:572-581
ISSN:1499-3872
Container-title:Hepatobiliary & Pancreatic Diseases International
language:en
Short-container-title:Hepatobiliary & Pancreatic Diseases International

Author:

Gkolfakis Paraskevas,Dimitriadis George,Triantafyllou Konstantinos

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference97 articles.

1. Insulin resistance: a metabolic pathway to chronic liver disease;Bugianesi;Hepatology,2005

2. Epidemiology and natural history of patients with NAFLD;Bhala;Curr Pharm Des,2013

3. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association;Chalasani;Hepatology,2012

4. Obesity and NAFLD: the role of bacteria and microbiota;Duseja;Clin Liver Dis,2014

5. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients;Targher;Diabetes Care,2007

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. INTESTINAL MICROBIOTA AND LIVER AND KIDNEY DISEASES;Перспективные исследования в психологии, спорте и здравоохранении: сборник статей международной научной конференции (Санкт-Петербург, Май 2024);2024-08-15

2. Roles and Mechanisms of Choline Metabolism in Nonalcoholic Fatty Liver Disease and Cancers;Frontiers in Bioscience-Landmark;2024-05-11

3. Sodium butyrate alleviates fructose-induced non-alcoholic fatty liver disease by remodeling gut microbiota to promote γ-amino butyric acid production;Food Science and Human Wellness;2024-03

4. Chronic Liver Disease and Promising  Therapeutic Strategy: A Concise Review;Pharmacognosy Magazine;2024-02-29

5. Gut microbiota and metabolic syndrome: What's new?;Metabolic Syndrome;2024